位置:首页 > 蛋白库 > NCKX5_HUMAN
NCKX5_HUMAN
ID   NCKX5_HUMAN             Reviewed;         500 AA.
AC   Q71RS6; A5X8Z8; A5X8Z9; Q14CT4; Q6DKH3;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 148.
DE   RecName: Full=Sodium/potassium/calcium exchanger 5;
DE   AltName: Full=Na(+)/K(+)/Ca(2+)-exchange protein 5;
DE   AltName: Full=Solute carrier family 24 member 5;
DE   Flags: Precursor;
GN   Name=SLC24A5 {ECO:0000303|PubMed:16357253, ECO:0000312|HGNC:HGNC:20611};
GN   Synonyms=JSX {ECO:0000303|Ref.1}, NCKX5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RA   Satoh J., Romero M.F.;
RT   "Cloning and characterization of a novel, renal divalent cation transporter
RT   (JSX).";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Retinal pigment epithelium;
RA   Mangini N.J., Kennedy B.G., Canfield V.A., Cheng K.C.;
RT   "Cloning and characterization of a K-dependent, Na-Ca2+ exchanger, member 5
RT   (slc24A5) expressed in human retinal pigment epithelium.";
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Retinal pigment epithelium;
RA   Mangini N.J., Kennedy B.G., Canfield V.A., Cheng K.C.;
RT   "Molecular cloning of a splice variant of SLC24A5 from human retinal
RT   pigment epithelium.";
RL   Submitted (JUN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND VARIANT ALA-111.
RX   PubMed=16357253; DOI=10.1126/science.1116238;
RA   Lamason R.L., Mohideen M.-A.P.K., Mest J.R., Wong A.C., Norton H.L.,
RA   Aros M.C., Jurynec M.J., Mao X., Humphreville V.R., Humbert J.E., Sinha S.,
RA   Moore J.L., Jagadeeswaran P., Zhao W., Ning G., Makalowska I.,
RA   McKeigue P.M., O'Donnell D., Kittles R., Parra E.J., Mangini N.J.,
RA   Grunwald D.J., Shriver M.D., Canfield V.A., Cheng K.C.;
RT   "SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish
RT   and humans.";
RL   Science 310:1782-1786(2005).
RN   [7]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [8]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND CHARACTERIZATION
RP   OF VARIANT ALA-111.
RX   PubMed=18166528; DOI=10.1074/jbc.m707521200;
RA   Ginger R.S., Askew S.E., Ogborne R.M., Wilson S., Ferdinando D., Dadd T.,
RA   Smith A.M., Kazi S., Szerencsei R.T., Winkfein R.J., Schnetkamp P.P.,
RA   Green M.R.;
RT   "SLC24A5 encodes a trans-Golgi network protein with potassium-dependent
RT   sodium-calcium exchange activity that regulates human epidermal
RT   melanogenesis.";
RL   J. Biol. Chem. 283:5486-5495(2008).
RN   [9]
RP   INVOLVEMENT IN OCA6.
RX   PubMed=23364476; DOI=10.1038/jid.2013.49;
RA   Wei A.H., Zang D.J., Zhang Z., Liu X.Z., He X., Yang L., Wang Y.,
RA   Zhou Z.Y., Zhang M.R., Dai L.L., Yang X.M., Li W.;
RT   "Exome sequencing identifies SLC24A5 as a candidate gene for nonsyndromic
RT   oculocutaneous albinism.";
RL   J. Invest. Dermatol. 133:1834-1840(2013).
RN   [10]
RP   VARIANT ALA-111, INVOLVEMENT IN SHEP4, AND POLYMORPHISM.
RX   PubMed=17999355; DOI=10.1086/522235;
RA   Stokowski R.P., Pant P.V.K., Dadd T., Fereday A., Hinds D.A., Jarman C.,
RA   Filsell W., Ginger R.S., Green M.R., van der Ouderaa F.J., Cox D.R.;
RT   "A genomewide association study of skin pigmentation in a South Asian
RT   population.";
RL   Am. J. Hum. Genet. 81:1119-1132(2007).
CC   -!- FUNCTION: Calcium, potassium:sodium antiporter that transports 1 Ca(2+)
CC       and 1 K(+) to the melanosome in exchange for 4 cytoplasmic Na(+)
CC       (PubMed:18166528). Involved in pigmentation, possibly by participating
CC       in ion transport in melanosomes (PubMed:16357253, PubMed:18166528).
CC       Predominant sodium-calcium exchanger in melanocytes (PubMed:16357253,
CC       PubMed:18166528). {ECO:0000269|PubMed:16357253,
CC       ECO:0000269|PubMed:18166528}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(out) + K(+)(out) + 4 Na(+)(in) = Ca(2+)(in) + K(+)(in)
CC         + 4 Na(+)(out); Xref=Rhea:RHEA:69967, ChEBI:CHEBI:29101,
CC         ChEBI:CHEBI:29103, ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000305|PubMed:18166528};
CC   -!- INTERACTION:
CC       Q71RS6; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12163679, EBI-16439278;
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane
CC       {ECO:0000269|PubMed:18166528}; Multi-pass membrane protein
CC       {ECO:0000255}. Melanosome {ECO:0000269|PubMed:17081065}. Note=Enriched
CC       in late-stage melanosomes. {ECO:0000269|PubMed:17081065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q71RS6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q71RS6-2; Sequence=VSP_047596;
CC   -!- POLYMORPHISM: Genetic variants in SLC24A5 define the skin/hair/eye
CC       pigmentation variation locus 4 (SHEP4) [MIM:113750]. Hair, eye and skin
CC       pigmentation are among the most visible examples of human phenotypic
CC       variation, with a broad normal range that is subject to substantial
CC       geographic stratification. In the case of skin, individuals tend to
CC       have lighter pigmentation with increasing distance from the equator. By
CC       contrast, the majority of variation in human eye and hair color is
CC       found among individuals of European ancestry, with most other human
CC       populations fixed for brown eyes and black hair.
CC       {ECO:0000269|PubMed:17999355}.
CC   -!- POLYMORPHISM: The Ala-111 allele predominates (93 to 100%) in African
CC       and East Asian populations. In contrast, the Thr-111 allele is nearly
CC       fixed (98.7 to 100%) in European populations, is associated with a
CC       substantial reduction in regional heterozygosity, and correlates with
CC       lighter skin pigmentation in admixed populations.
CC       {ECO:0000269|PubMed:17999355}.
CC   -!- DISEASE: Albinism, oculocutaneous, 6 (OCA6) [MIM:113750]: A disorder
CC       characterized by a reduction or complete loss of melanin in the skin,
CC       hair and eyes. Patients show reduced or lacking pigmentation often
CC       accompanied by eye symptoms such as photophobia, strabismus, moderate
CC       to severe visual impairment, and nystagmus.
CC       {ECO:0000269|PubMed:23364476}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the Ca(2+):cation antiporter (CaCA) (TC 2.A.19)
CC       family. SLC24A subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Skin-deep - Issue 74 of
CC       September 2006;
CC       URL="https://web.expasy.org/spotlight/back_issues/074";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF348468; AAQ15116.1; -; mRNA.
DR   EMBL; DQ665306; ABG66958.1; -; mRNA.
DR   EMBL; DQ665307; ABG66959.1; -; mRNA.
DR   EMBL; AC090526; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC073944; AAH73944.1; -; mRNA.
DR   EMBL; BC113628; AAI13629.1; -; mRNA.
DR   EMBL; BC113630; AAI13631.1; -; mRNA.
DR   EMBL; BC143950; AAI43951.1; -; mRNA.
DR   CCDS; CCDS10128.1; -. [Q71RS6-1]
DR   RefSeq; NP_995322.1; NM_205850.2. [Q71RS6-1]
DR   AlphaFoldDB; Q71RS6; -.
DR   BioGRID; 129632; 4.
DR   IntAct; Q71RS6; 4.
DR   STRING; 9606.ENSP00000341550; -.
DR   TCDB; 2.A.19.4.6; the ca(2+):cation antiporter (caca) family.
DR   iPTMnet; Q71RS6; -.
DR   PhosphoSitePlus; Q71RS6; -.
DR   BioMuta; SLC24A5; -.
DR   DMDM; 74749781; -.
DR   MassIVE; Q71RS6; -.
DR   PaxDb; Q71RS6; -.
DR   PeptideAtlas; Q71RS6; -.
DR   PRIDE; Q71RS6; -.
DR   ProteomicsDB; 68623; -. [Q71RS6-1]
DR   ProteomicsDB; 754; -.
DR   Antibodypedia; 24489; 98 antibodies from 28 providers.
DR   DNASU; 283652; -.
DR   Ensembl; ENST00000341459.8; ENSP00000341550.3; ENSG00000188467.11. [Q71RS6-1]
DR   Ensembl; ENST00000449382.2; ENSP00000389966.2; ENSG00000188467.11. [Q71RS6-2]
DR   GeneID; 283652; -.
DR   KEGG; hsa:283652; -.
DR   MANE-Select; ENST00000341459.8; ENSP00000341550.3; NM_205850.3; NP_995322.1.
DR   UCSC; uc001zwe.4; human. [Q71RS6-1]
DR   CTD; 283652; -.
DR   DisGeNET; 283652; -.
DR   GeneCards; SLC24A5; -.
DR   HGNC; HGNC:20611; SLC24A5.
DR   HPA; ENSG00000188467; Tissue enriched (skin).
DR   MalaCards; SLC24A5; -.
DR   MIM; 113750; phenotype.
DR   MIM; 609802; gene.
DR   neXtProt; NX_Q71RS6; -.
DR   OpenTargets; ENSG00000188467; -.
DR   Orphanet; 370097; Oculocutaneous albinism type 6.
DR   PharmGKB; PA134868972; -.
DR   VEuPathDB; HostDB:ENSG00000188467; -.
DR   eggNOG; KOG1307; Eukaryota.
DR   GeneTree; ENSGT01030000234532; -.
DR   HOGENOM; CLU_007948_5_0_1; -.
DR   InParanoid; Q71RS6; -.
DR   OMA; ENMGYHA; -.
DR   OrthoDB; 1168500at2759; -.
DR   PhylomeDB; Q71RS6; -.
DR   TreeFam; TF318759; -.
DR   PathwayCommons; Q71RS6; -.
DR   Reactome; R-HSA-425561; Sodium/Calcium exchangers.
DR   Reactome; R-HSA-5619036; Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6).
DR   SignaLink; Q71RS6; -.
DR   SIGNOR; Q71RS6; -.
DR   BioGRID-ORCS; 283652; 11 hits in 1064 CRISPR screens.
DR   ChiTaRS; SLC24A5; human.
DR   GeneWiki; SLC24A5; -.
DR   GenomeRNAi; 283652; -.
DR   Pharos; Q71RS6; Tbio.
DR   PRO; PR:Q71RS6; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q71RS6; protein.
DR   Bgee; ENSG00000188467; Expressed in skin of abdomen and 48 other tissues.
DR   ExpressionAtlas; Q71RS6; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:MGI.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0005262; F:calcium channel activity; IBA:GO_Central.
DR   GO; GO:0008273; F:calcium, potassium:sodium antiporter activity; IDA:ARUK-UCL.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0070509; P:calcium ion import; IDA:ARUK-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; IDA:MGI.
DR   GO; GO:0006811; P:ion transport; TAS:Reactome.
DR   GO; GO:0042438; P:melanin biosynthetic process; IEA:Ensembl.
DR   GO; GO:0030318; P:melanocyte differentiation; IBA:GO_Central.
DR   GO; GO:0048022; P:negative regulation of melanin biosynthetic process; IEA:Ensembl.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.1420.30; -; 2.
DR   InterPro; IPR004481; K/Na/Ca-exchanger.
DR   InterPro; IPR004837; NaCa_Exmemb.
DR   InterPro; IPR044880; NCX_ion-bd_dom_sf.
DR   InterPro; IPR030245; SLC24A5.
DR   PANTHER; PTHR10846; PTHR10846; 1.
DR   PANTHER; PTHR10846:SF61; PTHR10846:SF61; 1.
DR   Pfam; PF01699; Na_Ca_ex; 2.
DR   TIGRFAMs; TIGR00367; TIGR00367; 1.
PE   1: Evidence at protein level;
KW   Albinism; Alternative splicing; Antiport; Calcium; Calcium transport;
KW   Golgi apparatus; Ion transport; Membrane; Potassium; Potassium transport;
KW   Reference proteome; Sensory transduction; Signal; Sodium; Sodium transport;
KW   Symport; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..29
FT                   /evidence="ECO:0000255"
FT   CHAIN           30..500
FT                   /note="Sodium/potassium/calcium exchanger 5"
FT                   /id="PRO_0000045753"
FT   TOPO_DOM        30..66
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        67..87
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        88..111
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        112..132
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        133..136
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        137..157
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        158..169
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        170..190
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        191..195
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        196..216
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        217..302
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        303..323
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        324..333
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        334..354
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        355..368
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        369..389
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        390..399
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        400..420
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        421..437
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        438..458
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        459..468
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        469..489
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        490..500
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         41..101
FT                   /note="GNSTQCVISPSSEFPEGFFTRQERRDGGIIIYFLIIVYMFMAISIVCDEYFL
FT                   PSLEIISES -> A (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_047596"
FT   VARIANT         111
FT                   /note="T -> A (associated with SHEP4; greatly reduced
FT                   exchange activity; dbSNP:rs1426654)"
FT                   /evidence="ECO:0000269|PubMed:16357253,
FT                   ECO:0000269|PubMed:17999355, ECO:0000269|PubMed:18166528"
FT                   /id="VAR_024922"
SQ   SEQUENCE   500 AA;  54888 MW;  D8E91A017C9651ED CRC64;
     MQTKGGQTWA RRALLLGILW ATAHLPLSGT SLPQRLPRAT GNSTQCVISP SSEFPEGFFT
     RQERRDGGII IYFLIIVYMF MAISIVCDEY FLPSLEIISE SLGLSQDVAG TTFMAAGSSA
     PELVTAFLGV FITKGDIGIS TILGSAIYNL LGICAACGLL SNTVSTLSCW PLFRDCAAYT
     ISAAAVLGII YDNQVYWYEG ALLLLIYGLY VLVLCFDIKI NQYIIKKCSP CCACLAKAME
     RSEQQPLMGW EDEGQPFIRR QSRTDSGIFY EDSGYSQLSI SLHGLSQVSE DPPSVFNMPE
     ADLKRIFWVL SLPIITLLFL TTPDCRKKFW KNYFVITFFM SAIWISAFTY ILVWMVTITG
     ETLEIPDTVM GLTLLAAGTS IPDTIASVLV ARKGKGDMAM SNIVGSNVFD MLCLGIPWFI
     KTAFINGSAP AEVNSRGLTY ITISLNISII FLFLAVHFNG WKLDRKLGIV CLLSYLGLAT
     LSVLYELGII GNNKIRGCGG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025